>
Switch to:

Keros Therapeutics Price-to-Free-Cash-Flow

: (As of Today)
View and export this data going back to 2020. Start your Free Trial

As of today (2021-01-23), Keros Therapeutics's share price is $67.150000. Keros Therapeutics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $-1.86. Hence, Keros Therapeutics's Price-to-Free-Cash-Flow Ratio for today is .

Keros Therapeutics's Free Cash Flow per Share for the three months ended in Sep. 2020 was $-0.54. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-1.86.

Keros Therapeutics Price-to-Free-Cash-Flow Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Keros Therapeutics Annual Data
Dec18 Dec19
Price-to-Free-Cash-Flow 0.00 0.00

Keros Therapeutics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

Keros Therapeutics Price-to-Free-Cash-Flow Distribution

* The bar in red indicates where Keros Therapeutics's Price-to-Free-Cash-Flow falls into.


Keros Therapeutics Price-to-Free-Cash-Flow Calculation

Keros Therapeutics's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=67.150000/-1.863
=

Keros Therapeutics's Share Price of today is $67.150000.
Keros Therapeutics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2020 was -0.302 (Dec. 2019 ) + -0.456 (Mar. 2020 ) + -0.565 (Jun. 2020 ) + -0.54 (Sep. 2020 ) = $-1.86.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Keros Therapeutics  (NAS:KROS) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

Keros Therapeutics Price-to-Free-Cash-Flow Related Terms

Keros Therapeutics Price-to-Free-Cash-Flow Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)